Event & Symposium
June 17, 2025
Riyadh, KSA
Official Invitation
Saudi GU Working Group Annual Scientific Sessions: Advancing Multidisciplinary Care in Genitourinary Malignancies
The Steering Committee of the Saudi Genitourinary (GU) Working Group cordially invites oncologists, urologic surgeons, and healthcare practitioners across the Kingdom to the official Scientific Working Sessions and Multidisciplinary Symposium. This landmark event unifies leading clinical experts to discuss therapeutic evolutions, localized referral pathways, and modern patient management.
Figure 1: Official Saudi GU Working Group Symposium invitation banner, convened under scientific partnership with the Saudi Uro-Oncology Group.
Date & ScheduleTuesday, 17 June 2025
LocationRiyadh, Saudi Arabia
AccreditationCME Accredited Event
Target AudienceUrologists & Oncologists
1. About the Scientific Meeting
Genitourinary cancers represent a significant healthcare priority across the Gulf region. In response to recent landmark data in systemic immunotherapies, targeted radioligands, and antibody-drug conjugates (ADCs), the Saudi Genitourinary Working Group convenes this full-day symposium to bridge emerging global science with routine clinical practice across Saudi institutions.
The program gathers department chairs, senior consultants, and fellows from tertiary centers including King Faisal Specialist Hospital & Research Centre (KFSH&RC), King Fahd Medical City (KFMC), King Fahd Specialist Hospital Dammam, and Ministry of Defense Health Services (MODHS).
2. Core Scientific Agenda & Thematic Sessions
Session 01 • Urothelial Carcinoma
Transforming Urothelial Cancer Care
Focus: Implementation of first-line Enfortumab Vedotin plus Pembrolizumab (EV-302), sequencing post-platinum maintenance immunotherapy, and quality indicators in Transurethral Resection of Bladder Tumor (TURBT).
Session 02 • Prostate Cancer
Precision Medicine & Radioligands
Focus: Earlier integration of Lutetium-177 vipivotide tetraxetan (PSMAfore data), PARP inhibitor combinations in BRCA-altered metastatic castration-resistant disease, and treatment intensification in mHSPC.
Session 03 • Healthcare Policy
National Referral Checklists & MDTs
Focus: Establishing rapid-access hematuria referral criteria, overcoming inter-facility bottlenecks, and standardizing multidisciplinary tumor boards across regional health clusters.
The formal meeting invitation detailing the scientific agenda, distinguished keynote speakers, and session timings is available for direct download below:
Official Invitation & Program Guide (PDF)
Download the high-resolution invitation circular and comprehensive conference timetable for the June 17th working sessions.